Navigation Links
Pharma CI Conference Amy Yueh Pays $52,000 to Apaporis LLC to Satisfy Judgment Against Her In Superior Court Of New Jersey Case
Date:1/26/2010

TEANECK, N.J., Jan. 26 /PRNewswire/ -- Amy Yueh, the organizer of the Pharma CI Conference, who was sued in 2008 for alleged misappropriation of her employer's assets, has made payment of $52,000 by court order following judgment entered against her in the Superior Court of New Jersey. Yueh's trial took place in Hackensack, NJ.

Ellen Koblitz, Presiding Judge of the Superior Court of New Jersey stated in her ruling that Yueh "clearly took advantage of her employer by misleading 2008 conference participants." The decision represents compensation for "lost opportunity to compete on a level playing field had Yueh left and set up her own conference without misleading the potential participants."

In reaching decision, Judge Koblitz heard 3 1/2 days of testimony by Amy Yueh under questioning by lawyers for the prosecution. The Judge also accepted the introduction of testimony provided in depositions by former SCIP (Society of Competitive Intelligence Professionals) Presidents Cliff Kalb and Martha Matteo.

Yueh's motion to introduce testimony by Steve Levy of Fletcher CSI and her sister, Kelly Yueh, was denied by Judge Koblitz.

As part of the pre-trial proceedings counsel at Pfizer, Johnson & Johnson, Merck, sanofi-aventis, Bristol-Myers Squibb, and Novartis were subpoenaed in request of files detailing Yueh's email communications with various employees within the companies. The drug firms were helpful and the information provided was also recovered from her computer by forensic experts.

Previous articles and press releases on the case may be found at:

http://news.findlaw.com/prnewswire/20080813/13aug20080904.html

http://www.genengnews.com/news/bnitem.aspx?name=41654272

http://www.prnewswire.com/news-releases/50000-judgment-entered-against-defendant-amy-yueh-pharma-ci-conference-organizer-in-superior-court-of-new-jersey-62134257.html

http://www.njbiz.com/article.asp?aID=79155

Amy Yueh revealed in court documents that the 2008 Pharma CI Conference had revenues of $417,145 and net profits of $285,156.

The legal action was initiated in the Superior Court of New Jersey against Amy Yueh and her companies Acralinx Agenda and Amintell LLC.

Further litigation is pending.

CONTACT:  Mark Alexay, +1-201-452-4023, malexay@pharmabiotechci.com

SOURCE Apaporis LLC


'/>"/>
SOURCE Apaporis LLC
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/2/2017)... , Oct. 2, 2017  AllianceRx Walgreens Prime, ... formed by Walgreens and pharmacy benefit manager Prime Therapeutics ... new brand, which included the unveiling of new signage ... , as well as at a few other company-owned ... new brand to patients, some of whom will begin ...
(Date:9/28/2017)... Sept. 28, 2017 Cohen Veterans Bioscience and ... use of wearable and home sensors for real-time monitoring ... Signal Foundation, a nonprofit organization focused on disruptive health ... an affordable analytical system to record and integrate behavioral, ... ...
(Date:9/25/2017)... 2017  EpiVax, Inc., a leader in the ... today announced the launch of EpiVax Oncology Inc., ... therapeutic cancer vaccines. EpiVax has provided $500,000 in ... enabling technologies to the new precision immunotherapy venture. ... Oncology as Chief Executive Officer. Gad brings over ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...
(Date:10/13/2017)... ... 13, 2017 , ... “America On The Brink”: the Christian history of the ... is the creation of published author, William Nowers. Captain Nowers and his wife, ... he spent thirty years in the Navy. Following his career as a naval ...
(Date:10/12/2017)... CA (PRWEB) , ... October 12, 2017 , ... ... Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent technology. ... a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances can ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... , ... October 12, 2017 , ... The American College ... to Carol Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in ... , In honor of Morris F. Collen, a pioneer in the field of medical ...
Breaking Medicine News(10 mins):